Racial/ethnic differences in dyslipidemia patterns

Circulation

Volumn 129, Issue 5, 2014, Pages 570-579

  Frank, Ariel T H ^a   Zhao, Beinan ^a   Jose, Powell O ^a   Azar, Kristen M J ^a   Fortmann, Stephen P ^b   Palaniappan, Latha P ^a  

^a PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^b CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

epidemiology; hyperlipoproteinemias; lipids; lipoproteins; pharmaceutical preparations; risk factors

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; ARTICLE; ASIAN AMERICAN; BODY MASS; CAUCASIAN; CHINESE; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; DYSLIPIDEMIA; ETHNIC DIFFERENCE; FEMALE; FILIPINO; HEALTH CARE ORGANIZATION; HISPANIC; HUMAN; HYPERTRIGLYCERIDEMIA; INDIAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTPATIENT; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RACE DIFFERENCE; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; UNITED STATES;

EPIDEMIOLOGY; HYPERLIPOPROTEINEMIAS; LIPIDS; LIPOPROTEINS; PHARMACEUTICAL PREPARATIONS; RISK FACTORS;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ASIAN AMERICANS; CALIFORNIA; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MEXICAN AMERICANS; MIDDLE AGED; RISK FACTORS; TRIGLYCERIDES;

EID: 84893240499     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.005757     Document Type: Article

References (47)

1. Humes KR, Jones NA, Ramirez RR. Overview of Race and Hispanic Origin: 2010. Washington, DC: US Census Bureau; 2011.
2. US Census Bureau. Table 4: projections of the population by sex, race, and Hispanic origin for the United States: 2015 to 2060. In: 2012 National Population Projections: Summary Tables. Washington, DC: US Census Bureau; 2012.
3. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Soliman EZ, Sorlie PD, Sotoodehnia N, Turan TN, Virani SS, Wong ND, Woo D, Turner MB; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:e2-e220.
4. Gillum RF, Mehari A, Curry B, Obisesan TO. Racial and geographic variation in coronary heart disease mortality trends. BMC Public Health. 2012;12:410.
5. Klatsky AL, Tekawa I. Health problems and hospitalizations among Asian-American ethnic groups. Ethn Dis. 2005;15:753-760.
6. Holland AT, Wong EC, Lauderdale DS, Palaniappan LP. Spectrum of cardiovascular diseases in Asian-American racial/ethnic subgroups. Ann Epidemiol. 2011;21:608-614.
7. Morgenstern LB, Smith MA, Lisabeth LD, Risser JM, Uchino K, Garcia N, Longwell PJ, McFarling DA, Akuwumi O, Al-Wabil A, Al-Senani F, Brown DL, Moyé LA. Excess stroke in Mexican Americans compared with non-Hispanic Whites: the Brain Attack Surveillance in Corpus Christi Project. Am J Epidemiol. 2004;160:376-383.
8. White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, Sacco RL. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111:1327-1331.
9. Cohen JD, Cziraky MJ, Cai Q, Wallace A, Wasser T, Crouse JR, Jacobson TA. 30-Year trends in serum lipids among United States adults: results from the National Health and Nutrition Examination Surveys II, III, and 1999-2006. Am J Cardiol. 2010;106:969-975.
10. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
11. Centers for Disease Control and Prevention. National Health and Examination Survey: note on 2007-2010 sampling methodology. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchs/ nhanes/nhanes2007- 2008/sampling-0708.htm. Accessed April 11, 2013.
12. Holland AT, Palaniappan LP. Problems with the collection and interpretation of Asian-American health data: omission, aggregation, and extrapolation. Ann Epidemiol. 2012;22:397-405.
13. Huxley RR, Barzi F, Lam TH, Czernichow S, Fang X, Welborn T, Shaw J, Ueshima H, Zimmet P, Jee SH, Patel JV, Caterson I, Perkovic V, Woodward M; Asia Pacific Cohort Studies Collaboration and the Obesity in Asia Collaboration. Isolated low levels of high-density lipoprotein cholesterol are associated with an increased risk of coronary heart disease: an individual participant data meta-analysis of 23 studies in the Asia-Pacific region. Circulation. 2011;124:2056-2064.
14. Rutherford JN, McDade TW, Feranil AB, Adair LS, Kuzawa CW. High prevalence of low HDL-c in the Philippines compared to the US: population differences in associations with diet and BMI. Asia Pac J Clin Nutr. 2010;19:57-67.
15. Misra A, Khurana L. Obesity-related non-communicable diseases: South Asians vs White Caucasians. Int J Obes (Lond). 2011;35:167-187.
16. Karthikeyan G, Teo KK, Islam S, McQueen MJ, Pais P, Wang X, Sato H, Lang CC, Sitthi-Amorn C, Pandey MR, Kazmi K, Sanderson JE, Yusuf S. Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study. J Am Coll Cardiol. 2009;53:244-253.
17. Truesdale KP, Stevens J, Cai J. Impact of body mass index levels on lipid abnormalities in Chinese Asians, American Blacks and American Whites: the People's Republic of China (PRC) and Atherosclerosis Risk in Communities (ARIC) Studies. Atherosclerosis. 2011;218:517-523.
18. Goff DC Jr, Bertoni AG, Kramer H, Bonds D, Blumenthal RS, Tsai MY, Psaty BM. Dyslipidemia prevalence, treatment, and control in the Multi- Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation. 2006;113:647-656.
19. Chandalia M, Mohan V, Adams-Huet B, Deepa R, Abate N. Ethnic difference in sex gap in high-density lipoprotein cholesterol between Asian Indians and Whites. J Investig Med. 2008;56:574-580.
20. Derby CA, Wildman RP, McGinn AP, Green RR, Polotsky AJ, Ram KT, Barnhart J, Weiss G, Santoro N. Cardiovascular risk factor variation within a Hispanic cohort: SWAN, the Study of Women's Health Across the Nation. Ethn Dis. 2010;20:396-402.
21. Daviglus ML, Talavera GA, Avilés-Santa ML, Allison M, Cai J, Criqui MH, Gellman M, Giachello AL, Gouskova N, Kaplan RC, LaVange L, Penedo F, Perreira K, Pirzada A, Schneiderman N, Wassertheil-Smoller S, Sorlie PD, Stamler J. Prevalence of major cardiovascular risk factors and cardiovascular diseases among Hispanic/Latino individuals of diverse backgrounds in the United States. JAMA. 2012;308:1775-1784.
22. Mensah GA. Eliminating disparities in cardiovascular health: six strategic imperatives and a framework for action. Circulation. 2005; 111:1332-1336.
23. US Department of Health and Human Services. HHS Action Plan to Reduce Racial and Ethnic Disparities: A Nation Free of Disparities in Health and Health Care. Washington, DC: US Department of Health and Human Services; 2011.
24. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care (With CD). Washington, DC: National Academies Press; 2003.
25. Palaniappan LP, Wong EC, Shin JJ, Moreno MR, Otero-Sabogal R. Collecting patient race/ethnicity and primary language data in ambulatory care settings: a case study in methodology. Health Serv Res. 2009;44(pt 1):1750-1761.
26. Wong EC, Palaniappan LP, Lauderdale DS. Using name lists to infer Asian racial/ethnic subgroups in the healthcare setting. Med Care. 2010;48:540-546.
27. Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipids and lipoproteins in US adults, 1988-2010. JAMA. 2012;308:1545-1554.
28. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2012;35:S64-S71.
29. Hyre AD, Muntner P, Menke A, Raggi P, He J. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among US adults. Ann Epidemiol. 2007;17:548-555.
30. Palaniappan LP, Araneta MR, Assimes TL, Barrett-Connor EL, Carnethon MR, Criqui MH, Fung GL, Narayan KM, Patel H, Taylor- Piliae RE, Wilson PW, Wong ND; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Peripheral Vascular Disease; American Heart Association Council on Nutrition, Physical Activity, and Metabolism; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Nursing; Council on Cardiovascular Nursing. Call to action: cardiovascular disease in Asian Americans: a science advisory from the American Heart Association. Circulation. 2010;122:1242-1252.
31. Benfante R. Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review. Hum Biol. 1992;64:791-805.
32. Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, Goldberg AC, Howard WJ, Jacobson MS, Kris-Etherton PM, Lennie TA, Levi M, Mazzone T, Pennathur S; American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2011;123:2292-2333.
33. Bainey KR, Jugdutt BI. Increased burden of coronary artery disease in South-Asians living in North America: need for an aggressive management algorithm. Atherosclerosis. 2009;204:1-10.
34. Dodani S. Excess coronary artery disease risk in South Asian immigrants: can dysfunctional high-density lipoprotein explain increased risk? Vasc Health Risk Manag. 2008;4:953-961.
35. Palaniappan L, Wang Y, Fortmann SP. Coronary heart disease mortality for six ethnic groups in California, 1990-2000. Ann Epidemiol. 2004;14:499-506.
36. Wild SH, Laws A, Fortmann SP, Varady AN, Byrne CD. Mortality from coronary heart disease and stroke for six ethnic groups in California, 1985 to 1990. Ann Epidemiol. 1995;5:432-439.
37. Lanas F, Avezum A, Bautista LE, Diaz R, Luna M, Islam S, Yusuf S; INTERHEART Investigators in Latin America. Risk factors for acute myocardial infarction in Latin America: the INTERHEART Latin American study. Circulation. 2007;115:1067-1074.
38. Hertz RP, Unger AN, Cornell JA, Saunders E. Racial disparities in hypertension prevalence, awareness, and management. Arch Intern Med. 2005;165:2098-2104.
39. Jones DW, Chambless LE, Folsom AR, Heiss G, Hutchinson RG, Sharrett AR, Szklo M, Taylor HA Jr. Risk factors for coronary heart disease in African Americans: the Atherosclerosis Risk in Communities study, 1987- 1997. Arch Intern Med. 2002;162:2565-2571.
40. Ma J, Sehgal NL, Ayanian JZ, Stafford RS. National trends in statin use by coronary heart disease risk category. PLoS Med. 2005;2:e123.
41. Festa A, D'Agostino R Jr, Mykkänen L, Tracy R, Howard BV, Haffner SM. Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels: the Insulin Resistance Atherosclerosis Study. Arterioscler Thromb Vasc Biol. 1999;19:605-610.
42. Biswas S, Ghoshal PK, Mandal SC, Mandal N. Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease. J Cardiol. 2008;52:118-126.
43. Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol: Veterans Affairs High- Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med. 1999;341:410-418.
44. Coronary Drug Project Collaborators. Clofibrate and niacin in coronary heart disease. JAMA. 1975;231:360-381.
45. Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M; FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005;366:1849-1861.
46. Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365:2255-2267.
47. HPS2-THRIVE Collaborative Group. HPS2-THRIVE randomized placebo- controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment. Eur Heart J. 2013; 34:1279-91. and Kidney Diseases